Replicel Life Sciences Stock Operating Margin
| RP Stock | CAD 0.01 0.00 0.00% |
RepliCel Life Sciences fundamentals help investors to digest information that contributes to RepliCel Life's financial success or failures. It also enables traders to predict the movement of RepliCel Stock. The fundamental analysis module provides a way to measure RepliCel Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RepliCel Life stock.
| Last Reported | Projected for Next Year | ||
| Operating Profit Margin | (3.92) | (4.11) |
RepliCel | Operating Margin |
RepliCel Life Sciences Company Operating Margin Analysis
RepliCel Life's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current RepliCel Life Operating Margin | (0.74) % |
Most of RepliCel Life's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RepliCel Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
RepliCel Operating Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for RepliCel Life is extremely important. It helps to project a fair market value of RepliCel Stock properly, considering its historical fundamentals such as Operating Margin. Since RepliCel Life's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of RepliCel Life's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of RepliCel Life's interrelated accounts and indicators.
Click cells to compare fundamentals
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
RepliCel Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, RepliCel Life Sciences has an Operating Margin of -0.7414%. This is 97.89% lower than that of the Biotechnology sector and 99.34% lower than that of the Health Care industry. The operating margin for all Canada stocks is 86.54% lower than that of the firm.
RepliCel Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RepliCel Life's direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RepliCel Life could also be used in its relative valuation, which is a method of valuing RepliCel Life by comparing valuation metrics of similar companies.RepliCel Life is currently under evaluation in operating margin category among its peers.
RepliCel Life Current Valuation Drivers
We derive many important indicators used in calculating different scores of RepliCel Life from analyzing RepliCel Life's financial statements. These drivers represent accounts that assess RepliCel Life's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of RepliCel Life's important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 6.1M | 6.2M | 7.5M | 3.2M | 3.9M | 3.7M | |
| Enterprise Value | 6.6M | 6.2M | 7.3M | 2.8M | 4.7M | 8.4M |
RepliCel Fundamentals
| Return On Asset | -1.53 | ||||
| Profit Margin | 2.16 % | ||||
| Operating Margin | (0.74) % | ||||
| Current Valuation | 658.49 K | ||||
| Shares Outstanding | 65 M | ||||
| Shares Owned By Insiders | 59.39 % | ||||
| Number Of Shares Shorted | 520 | ||||
| Price To Earning | (1.05) X | ||||
| Price To Sales | 1.84 X | ||||
| Revenue | 353.74 K | ||||
| Gross Profit | 353.74 K | ||||
| EBITDA | (1.38 M) | ||||
| Net Income | (311.73 K) | ||||
| Cash And Equivalents | 1.16 M | ||||
| Cash Per Share | 0.04 X | ||||
| Total Debt | 813.19 K | ||||
| Current Ratio | 2.09 X | ||||
| Book Value Per Share | (0.07) X | ||||
| Cash Flow From Operations | (1.41 M) | ||||
| Short Ratio | 0.01 X | ||||
| Earnings Per Share | (0.02) X | ||||
| Target Price | 1.64 | ||||
| Beta | 0.95 | ||||
| Market Capitalization | 650.02 K | ||||
| Total Asset | 287.79 K | ||||
| Retained Earnings | (43.29 M) | ||||
| Working Capital | (1.44 M) | ||||
| Net Asset | 287.79 K |
About RepliCel Life Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze RepliCel Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RepliCel Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RepliCel Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.